作者: Michael Econs , Thomas Meitinger , Tim Matthias Strom , Ken White
DOI:
关键词:
摘要: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). further methods of diagnosing treating hypophosphatemic hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity FGF23 patient. also osteoporosis, dermatomyositis, coronary artery disease stimulating